Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05836324
Title	A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Incyte Corporation
Indications	peritoneal carcinoma cervical squamous cell carcinoma peritoneum cancer skin melanoma laryngeal squamous cell carcinoma endocervical adenocarcinoma ovarian carcinosarcoma hypopharynx cancer esophageal cancer malignant pleural mesothelioma oral squamous cell carcinoma triple-receptor negative breast cancer oropharynx cancer urinary bladder cancer fallopian tube carcinoma Advanced Solid Tumor fallopian tube cancer pancreatic adenocarcinoma ovary epithelial cancer colorectal cancer gastric adenocarcinoma lung non-small cell carcinoma renal cell carcinoma
Therapies	INCA33890
Age Groups:	senior \| adult
Covered Countries	USA \| ITA \| GBR \| FRA \| ESP \| DNK \| CHE